GlassScriptPhysician profile
Dusty D Best
NPI 1508564329
$1,983.89
in general payments reported to CMS, 2019-2025
19 companies · $493 in 2025
The $493 reported for 2025 was more than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $513 · 2024: $978 · 2025: $493.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,984.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,983.89 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $614.26 | 2023-2025 | Airsupra, Breztri, Farxiga |
| Otsuka America Pharmaceutical, INC. | $436.35 | 2023-2025 | Rexulti |
| Pfizer INC. | $224.63 | 2023-2025 | |
| Bayer Healthcare Pharmaceuticals INC. | $146.02 | 2024 | |
| Lilly USA, LLC | $136.32 | 2023-2025 | Mounjaro, Zepbound, Trulicity |
| Astellas Pharma US INC | $65.06 | 2024-2025 | Veozah |
| Hologic Sales and Service, LLC | $50.92 | 2025 | Aptima |
| Glaxosmithkline, LLC. | $44.90 | 2023 | Shingrix |
| Edwards Lifesciences Corporation | $38.45 | 2023 | Edwards Sapien 3 Transcatheter Heart Valve (Thv) |
| Exact Sciences Corporation | $36.52 | 2023 | Cologuard Collection Kit |
| Harmony Biosciences LLC | $28.28 | 2024 | |
| Amgen INC. | $27.00 | 2024 | Repatha, Otezla |
| Bard Peripheral Vascular, INC. | $25.40 | 2025 | Rotarexs 6 F X 135 Cm |
| Novo Nordisk INC | $23.22 | 2024 | Ozempic, Rybelsus |
| Neurocrine Biosciences, INC. | $22.35 | 2023 | Ingrezza |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Esperion Therapeutics, INC. | $21.26 | 2025 | Nexletol |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $16.18 | 2023 | Xifaxan, Trulance |
| Medtronic, INC. | $15.03 | 2025 | Inceptiv |
| Itamar Medical INC | $11.74 | 2023 | Watchpatone |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Dusty Best listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.